- List
- By Topic
- On Map
- Search Details

actovegin (4 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03469349 | Recruiting | Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
366 | All | 40 Years to 75 Years (Adult, Older Adult) | NCT03469349 | Actovegin-3001 2017-004741-24 |
APOLLO | May 1, 2018 | May 31, 2019 | May 31, 2019 | March 19, 2018 | August 20, 2018 |
|
||
2 | NCT01582854 | Completed Has Results |
Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
503 | All | 60 Years and older (Adult, Older Adult) | NCT01582854 | AV-2500-301-RD U1111-1132-3434 |
ARTEMIDA | June 2012 | November 2014 | November 2014 | April 23, 2012 | February 22, 2016 | February 22, 2016 |
|
|
3 | NCT00483730 | Completed | Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
569 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00483730 | AV-007-IM | December 2006 | May 2008 | December 2008 | June 7, 2007 | May 7, 2012 |
|
|||
4 | NCT03543917 | Completed | Post-Stroke Improvement of Motor Function |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
17 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03543917 | PSIOM | PSIOM | August 8, 2017 | August 30, 2018 | September 29, 2018 | June 1, 2018 | November 19, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.